Navigation Links
Kite Pharma to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Date:1/7/2014

LOS ANGELES, Jan. 7, 2014 /PRNewswire/ -- Kite Pharma today announced that Dr. Arie Belldegrun, Executive Chairman and Founder of Kite Pharma, will present at the 32nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014, at 1:30 p.m. Pacific Time.  The conference will be held at the Westin St. Francis Hotel in San Francisco, CA.

(Logo:  http://photos.prnewswire.com/prnh/20130513/MM13332LOGO )

About Kite Pharma

Kite Pharma, Inc. (Kite) is a privately held development stage biotechnology company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors. In partnership with the NCI Surgery Branch, Kite is advancing a pipeline of proprietary eACT™ product candidates, both CAR and TCR products, directed to a wide range of cancer indications. These novel personalized and targeted immunotherapies, which capitalize on the selectivity and potency of immune cells, are designed to provide significant and durable clinical benefit regardless of tumor origin, disease stage, and prior treatments. Kite's management team has a proven track record of building successful biotechnology companies and successfully developing cutting-edge immunotherapies and oncology treatments. Kite is based in Los Angeles, CA.  For more information, visit the company's website at http://www.kitepharma.com.

Kite Contact:
Dr. Arie Belldegrun
Chief Executive Officer & Executive Chairman
(310) 824-9999

For Media:
Justin Jackson
Burns McClellan
(212) 213-0006

SOURCE Kite Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics
2. Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
3. Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development
4. Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13
5. Ralphs Pharmacies Providing Prescriptions at No Upfront Cost for Customers Enrolled in the Public Health Insurance Marketplace
6. CVS/pharmacy Helps Customers Kick Off a Healthy New Year with Online Vitamin Resources and Huge Savings
7. Avanir Pharmaceuticals to Present at J.P. Morgan 32nd Annual Healthcare Conference
8. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
9. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
10. Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
11. Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... exercise of the underwriters, option to purchase 675,000 ... the company,s previously announced public offering of 4,500,000 ... are being offered by Aratana Therapeutics.  With the ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... Market Monitor : Global Chiral Separation Columns Market" ... chromatography is a technique involving two enantiomers of the ... consisting of a single enantiomer, thus possessing different elution ... such as cellulose. The chiral separation chromatography ...
(Date:9/18/2014)... , Sept. 18, 2014  Decision Resources ... the United States , 54 ... GlaxoSmithKline,s BRAF inhibitor Tafinlar for BRAF -mutation-positive ... who have prescribed GlaxoSmithKline,s MEK inhibitor Mekinist. Among ... percentage (42 percent and 43 percent, respectively) expects ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2Micro Market Monitor: Global Chiral Separation Columns Market 2At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2
... The award recognizes outstanding journalism demonstrating the ... discoveries and scientific,breakthroughs., WASHINGTON, June 19 ... announces the winners of the 7th Annual,Michael ... in honor of FBR,s,Chairman and 2008 Congressional ...
... Kendle (Nasdaq: KNDL ), a,leading global full-service ... its experts will present at the upcoming Drug,Information ... scheduled,for June 22-26, 2008, at the Boston Convention ... speak on key topics in the clinical,development industry, ...
Cached Medicine Technology:The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 3
(Date:9/18/2014)... Kent, WA Chiropractor Danene Saggau and the ... that Dawn Kelly has agreed to become the new Office ... to Ms. Kelly expanding her role within the practice, noting ... key contributor. “ Dawn Kelly brings to the clinic ... that will allow me to focus on the patient ...
(Date:9/18/2014)... Alexandria, VA — The Public Health ... communities have joined the growing ranks of those reaping ... decisions bring the number of governmental public health departments ... non-profit organization that administers the national public health accreditation ... of the public by advancing the quality and performance ...
(Date:9/18/2014)... -- Older people become more physically vulnerable during bereavement, ... stress hormones during bereavement changes with age, British researchers ... are more likely to have weakened immune systems and ... weeks and months after loss, we can suffer from ... of white blood cell and as such are essential ...
(Date:9/18/2014)... September 18, 2014 It’s been just a ... newest, patent pending bunion splint to website visitors, but already ... wrote: "I was absolutely delighted. It is perfect and I ... am wearing them. THANK YOU FOR LISTENING!!!" Another user ... saying, "The hole used to slip to the end of ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter , ... to emergency room waiting times, patients seeking care at larger ... the clock than those seen at smaller or more rural ... our ability to provide timely emergency care varies dramatically across ... of the new research, Dr. Renee Hsia, an associate professor ...
Breaking Medicine News(10 mins):Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3
... Iran: Revolution and Reproduction has been selected as this year,s ... Year of the Islamic Republic of Iran. Edited by Mohammad ... the first to attempt to explain why the fertility rate ... end of the 20th century. The prize is awarded by ...
... million deaths from cancer in Europe in 2011 according to ... Annals of Oncology today (Wednesday 9 February) [1]. ... for the first time in Europe a new mathematical model ... death rates for both men and women when compared to ...
... Scientific American MIND to present an event just in time ... what makes romantic relationships succeed or fail. The ... 2011, 7:00 PM - 8:30 PM at The New York ... City. According to Columbia University psychiatrist and neuroscientist Amir ...
... by Boston University School of Public Health (BUSPH) researchers ... help smokers quit, producing six-month abstinence rates nearly double ... study published online ahead of print in the American ... of respondents reported having quit smoking six months after ...
... TUESDAY, Feb. 8 (HealthDay News) -- Babies who are exposed ... virus have lower levels of antibodies to diseases such as ... Researchers collected serum samples from 104 HIV-infected and uninfected South ... again from 93 of the infants at 16 weeks of ...
... , TUESDAY, Feb. 8 (HealthDay News) -- In pregnant women, ... significantly higher blood pressure, new research suggests. The study ... had a lead level higher than about 1 microgram per ... lower than the safety thresholds set by the U.S Centers ...
Cached Medicine News:Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 3Health News:Electronic cigarettes hold promise as aid to quitting 2Health News:Mom's HIV May Lower Baby's Immunity to Other Diseases 2Health News:Lead Exposure May Raise Blood Pressure in Pregnancy 2
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... cover the range from 2ul to 5000ul. ... lock design prevents inadvertent volume change. Novel ... Whole pipette is autoclavable at 121C(250F). To ... Suitable for one-handed operation. Auto or ...
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
... In the specialty areas ... or intensive care work, it ... in your practice. Alokas motorized ... Doppler and Tissue Harmonic Echo ...
Medicine Products: